Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IONS | NBIX | MDGL | ||
| Company | Ionis Pharmaceuticals | Neurocrine Bioscienc | Madrigal Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 77.15 | 133.31 | 495.75 | ||
| High | 78.00 | 134.02 | 511.94 | ||
| Low | 74.49 | 131.36 | 492.50 | ||
| Latest | 76.36 | 132.38 | 501.49 | ||
| Change | -0.85 | -0.97 | +5.61 | ||
| % Change | -1.10% | -0.73% | +1.13% | ||
| Volume | 2,175,432 | 412,136 | 182,382 | ||
| 20-Day Average Volume | 1,822,931 | 1,086,765 | 341,526 | ||
| Previous Close | 77.21 | 133.35 | 495.88 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 79.77 | 139.61 | 558.90 | ||
| 20-Day Raw Stochastic | 13.42% | 6.75% | 12.35% | ||
| 20-Day Relative Strength | 44.99 | 38.31 | 40.58 | ||
| Weighted Alpha | +104.99 | -4.18 | +70.79 | ||
| Today's Opinion | 56% Buy | 8% Sell | 56% Buy | ||
| Previous Opinion | 64% Buy | 8% Sell | 56% Buy | ||
| Last Month's Opinion | 88% Buy | 88% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.29% since 01/09/26 | -2.45% since 01/09/26 | -2.16% since 01/09/26 | ||
| Low | 74.49 on 01/16/26 | 131.30 on 01/15/26 | 487.19 on 01/14/26 | ||
| High | 82.57 on 01/13/26 | 135.98 on 01/15/26 | 517.71 on 01/12/26 | ||
| 1-Month | |||||
| %Chg | -2.95% since 12/16/25 | -10.94% since 12/16/25 | -9.30% since 12/16/25 | ||
| Low | 74.49 on 01/16/26 | 131.30 on 01/15/26 | 487.19 on 01/14/26 | ||
| High | 86.15 on 01/07/26 | 150.47 on 12/17/25 | 615.00 on 12/24/25 | ||
| 3-Month | |||||
| %Chg | +4.09% since 10/16/25 | -3.68% since 10/16/25 | +13.76% since 10/16/25 | ||
| Low | 66.66 on 11/10/25 | 131.30 on 01/15/26 | 393.61 on 10/29/25 | ||
| High | 86.15 on 01/07/26 | 160.18 on 12/08/25 | 615.00 on 12/24/25 | ||
| 6-Month | |||||
| %Chg | +77.82% since 07/16/25 | -0.76% since 07/16/25 | +45.80% since 07/16/25 | ||
| Low | 40.03 on 08/07/25 | 123.67 on 08/08/25 | 286.44 on 07/30/25 | ||
| High | 86.15 on 01/07/26 | 160.18 on 12/08/25 | 615.00 on 12/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,506,011 | 13,295,796 | 11,261,931 | ||
| Shares Outstanding, K | 161,974 | 99,706 | 22,711 | ||
| Annual Sales | 705,140,000 | 2,355,300,000 | 180,130,000 | ||
| Annual Net Income | -453,900,000 | 341,300,000 | -465,890,000 | ||
| Last Quarter Sales | 156,720,000 | 794,900,000 | 287,270,000 | ||
| Last Quarter Net Income | -128,610,000 | 209,500,000 | -114,190,000 | ||
| 60-Month Beta | 0.28 | 0.28 | -1.00 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.61 on 10/29/25 | 2.04 on 10/28/25 | -5.08 on 11/04/25 | ||
| Latest Earnings Date | 02/18/26 | 02/05/26 | 02/25/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 32.38 | 0.00 | ||